Cash flow Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 11:09:20 2026-01-21 EST			5-day change	1st Jan Change
219.52 ^USD	+1.51%		+0.02%	-1.94%

01-13	Veeva Systems Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 01:30 PM
01-08	Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership	MT

0cd76fa156a3d1d5d56d5bacda8fec.HbR0e_0fWotzqL-FmkVkcNQCMvAVLH7B4YMMXMj8QVk.VNlHDMsyauxDmfDArTFdNpVbeKByFDP0oPN4Gq6RBBR32z4fin4_yTbk7g

Published financial data: VEEVA SYSTEMS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021	2022	2023	2024	2025
Revenues	1.47B	1.85B	2.16B	2.36B	2.75B
Total Revenues	1.47B	1.85B	2.16B	2.36B	2.75B
Cost of Goods Sold, Total	409M	504M	609M	677M	700M
Gross Profit	1.06B	1.35B	1.55B	1.69B	2.05B
Selling General & Admin Expenses, Total	384M	460M	566M	628M	657M
R&D Expenses	294M	382M	520M	629M	693M
Other Operating Expenses, Total	678M	842M	1.09B	1.26B	1.35B
Operating Income	378M	505M	459M	429M	696M
Interest And Investment Income	15.86M	14.73M	45.86M	134M	208M
Net Interest Expenses	15.86M	14.73M	45.86M	134M	208M
Currency Exchange Gains (Loss)	2.28M	-714K	591K	124K	-3.27M
Other Non Operating Income (Expenses)	1.15M	-	572K	-	611K
EBT, Excl. Unusual Items	397M	520M	506M	563M	902M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-3.08M	-7.2M	2.98M	24.82M	22.62M
Legal Settlements	-	-	-	-	-5M
EBT, Incl. Unusual Items	394M	512M	509M	588M	919M
Income Tax Expense	14M	84.92M	21.39M	62.32M	205M
Earnings From Continuing Operations	380M	427M	488M	526M	714M
Net Income to Company	380M	427M	488M	526M	714M
Net Income - (IS)	380M	427M	488M	526M	714M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	380M	427M	488M	526M	714M
Net Income to Common Excl. Extra Items	380M	427M	488M	526M	714M
Per Share Items
Net EPS - Basic	2.52	2.79	3.14	3.27	4.41
Basic EPS - Continuing Operations	2.52	2.79	3.14	3.27	4.41
Basic Weighted Average Shares Outstanding	151M	153M	155M	161M	162M
Net EPS - Diluted	2.36	2.63	3	3.22	4.32
Diluted EPS - Continuing Operations	2.36	2.63	3	3.22	4.32
Diluted Weighted Average Shares Outstanding	161M	162M	162M	163M	165M
Normalized Basic EPS	1.65	2.12	2.04	2.19	3.48
Normalized Diluted EPS	1.54	2	1.95	2.15	3.41
Supplemental Items
EBITDA	407M	533M	488M	462M	736M
EBITA	398M	524M	478M	448M	715M
EBIT	378M	505M	459M	429M	696M
EBITDAR	420M	547M	504M	478M	750M
Total Revenues (As Reported)	1.47B	1.85B	2.16B	2.36B	2.75B
Effective Tax Rate - (Ratio)	3.55	16.58	4.2	10.6	22.32
Current Domestic Taxes	11.87M	66.01M	140M	156M	307M
Current Foreign Taxes	2.82M	7.84M	8.51M	12.16M	10.9M
Total Current Taxes	14.7M	73.84M	149M	168M	318M
Deferred Domestic Taxes	-135K	2.82M	-120M	-103M	-109M
Deferred Foreign Taxes	-566K	8.26M	-7.82M	-1.98M	-3.67M
Total Deferred Taxes	-701K	11.08M	-128M	-105M	-112M
Normalized Net Income	248M	325M	316M	352M	564M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	235M	288M	349M	381M	397M
General and Administrative Expenses	149M	172M	218M	247M	261M
Research And Development Expense From Footnotes	294M	382M	520M	629M	693M
Net Rental Expense, Total	13M	14M	16M	16M	14M
Stock-Based Comp., COGS (Total)	32.54M	41.09M	56.6M	59.72M	57.97M
Stock-Based Comp., R&D Exp. (Total)	63.54M	83.84M	142M	173M	186M
Stock-Based Comp., S&M Exp. (Total)	40.57M	56.83M	87.51M	90.86M	90.18M
Stock-Based Comp., G&A Exp. (Total)	48.35M	52.88M	66.23M	70.27M	103M
Total Stock-Based Compensation	185M	235M	352M	394M	437M

Fiscal Period: January	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	731M	1.14B	886M	703M	1.12B
Short Term Investments	933M	1.24B	2.22B	3.32B	4.03B
Total Cash And Short Term Investments	1.66B	2.38B	3.1B	4.03B	5.15B
Accounts Receivable, Total	612M	694M	785M	889M	1.06B
Total Receivables	612M	694M	785M	889M	1.06B
Prepaid Expenses	35.17M	35.46M	81.46M	86.92M	101M
Other Current Assets, Total	440K	1.22M	-	-	-
Total Current Assets	2.31B	3.11B	3.97B	5B	6.31B
Gross Property Plant And Equipment	140M	134M	137M	141M	151M
Accumulated Depreciation	-29.62M	-30.27M	-32.12M	-36.76M	-31.45M
Net Property Plant And Equipment	111M	104M	105M	104M	120M
Goodwill	436M	440M	440M	440M	440M
Other Intangibles, Total	115M	102M	82.48M	63.02M	44.46M
Deferred Tax Assets Long-Term	14.1M	5.1M	137M	233M	344M
Deferred Charges Long-Term	42.07M	33.11M	31.82M	23.92M	26.38M
Other Long-Term Assets, Total	17.88M	25.13M	38.96M	43.3M	56.54M
Total Assets	3.05B	3.82B	4.8B	5.91B	7.34B
Liabilities
Accounts Payable, Total	23.25M	20.35M	41.68M	31.51M	30.45M
Accrued Expenses, Total	61.39M	69.94M	79.59M	76.41M	74.99M
Current Portion of Leases	11.72M	10.98M	11.31M	9.33M	9.97M
Current Income Taxes Payable	2.59M	7.76M	4.95M	11.86M	9.02M
Unearned Revenue Current, Total	617M	732M	869M	1.05B	1.27B
Total Current Liabilities	716M	841M	1.01B	1.18B	1.4B
Long-Term Leases	51.39M	43.61M	49.67M	46.44M	65.81M
Deferred Tax Liability Non Current	1.84M	2.22M	1.49M	2.05M	587K
Other Non Current Liabilities	10.57M	18.23M	30.08M	38.72M	42.59M
Total Liabilities	780M	905M	1.09B	1.27B	1.51B
Common Stock, Total	2K	2K	2K	2K	2K
Additional Paid In Capital	966M	1.2B	1.53B	1.92B	2.39B
Retained Earnings	1.3B	1.73B	2.21B	2.74B	3.45B
Comprehensive Income and Other	992K	-11.96M	-31.13M	-10.64M	-8.42M
Total Common Equity	2.27B	2.91B	3.72B	4.64B	5.83B
Total Equity	2.27B	2.91B	3.72B	4.64B	5.83B
Total Liabilities And Equity	3.05B	3.82B	4.8B	5.91B	7.34B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	152M	154M	160M	161M	163M
ECS Total Common Shares Outstanding	152M	154M	158M	161M	163M
Book Value / Share	14.9	18.88	23.48	28.8	35.87
Tangible Book Value	1.72B	2.37B	3.19B	4.14B	5.35B
Tangible Book Value Per Share	11.28	15.37	20.18	25.68	32.89
Total Debt	63.12M	54.59M	60.98M	55.78M	75.78M
Net Debt	-1.6B	-2.32B	-3.04B	-3.97B	-5.07B
Debt Equivalent Oper. Leases	104M	112M	128M	128M	112M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	3.04M	3.04M	3.04M	3.04M	3.04M
Buildings, Total	20.98M	20.98M	20.98M	20.98M	20.98M
Machinery, Total	22.3M	18.62M	16.23M	18.05M	7.77M
Full Time Employees	4.51K	5.48K	6.74K	7.17K	7.29K
Accumulated Allowance for Doubtful Accounts (Supple)	193K	473K	469K	520K	57K

Fiscal Period: January	2021	2022	2023	2024	2025
Net Income	380M	427M	488M	526M	714M
Depreciation & Amortization - CF	9.46M	8.45M	10.12M	13.63M	20.38M
Amortization of Goodwill and Intangible Assets - (CF)	20M	19M	19M	19M	19M
Depreciation & Amortization, Total	29.46M	27.45M	29.12M	32.63M	39.38M
Amortization of Deferred Charges, Total - (CF)	20.68M	26.05M	22.1M	18.18M	15.53M
(Gain) Loss on Sale of Investments - (CF)	3.13M	6.26M	-3.62M	-26.52M	-24.44M
Stock-Based Compensation (CF)	185M	235M	352M	394M	437M
Provision and Write-off of Bad Debts	-307K	272K	256K	693K	-
Other Operating Activities, Total	8.93M	21.74M	-114M	-93.9M	-99.52M
Change In Accounts Receivable	-188M	-83.08M	-91.08M	-104M	-169M
Change In Accounts Payable	754K	-3M	21.43M	-10.23M	-1.96M
Change in Unearned Revenues	147M	116M	140M	188M	228M
Change In Income Taxes	-3.02M	5.28M	-2.82M	6.92M	-2.84M
Change in Other Net Operating Assets	-32.4M	-14.68M	-60.66M	-20.03M	-46.45M
Cash from Operations	551M	764M	780M	911M	1.09B
Capital Expenditure	-8.68M	-14.21M	-13.51M	-26.2M	-20.52M
Cash Acquisitions	-	-7.78M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-325M	-324M	-994M	-1.05B	-680M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-334M	-346M	-1.01B	-1.08B	-700M
Long-Term Debt Repaid, Total	-1.04M	-384K	-	-	-
Total Debt Repaid	-1.04M	-384K	-	-	-
Issuance of Common Stock	34.86M	51.54M	43.65M	62.69M	106M
Repurchase of Common Stock	-	-55.29M	-63.03M	-78.88M	-79.42M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	33.82M	-4.14M	-19.38M	-16.19M	26.12M
Foreign Exchange Rate Adjustments	484K	-4.66M	-4.99M	-1.78M	-1.74M
Net Change in Cash	252M	410M	-252M	-183M	414M
Supplemental Items
Cash Income Tax Paid (Refund)	18.1M	58.63M	168M	134M	322M
Levered Free Cash Flow	423M	632M	707M	752M	943M
Unlevered Free Cash Flow	423M	632M	707M	752M	943M
Change In Net Working Capital	39.76M	-41.69M	-30.09M	-65.28M	-35.77M
Net Debt Issued / Repaid	-1.04M	-384K	-	-	-

Fiscal Period: January	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.88	9.21	6.66	5.01	6.57
Return on Total Capital	11.66	11.93	8.51	6.33	8.21
Return On Equity %	19.33	16.51	14.72	12.58	13.63
Return on Common Equity	19.33	16.51	14.72	12.58	13.63
Margin Analysis
Gross Profit Margin %	72.09	72.79	71.72	71.35	74.53
SG&A Margin	26.22	24.83	26.28	26.57	23.94
EBITDA Margin %	27.8	28.8	22.65	19.54	26.79
EBITA Margin %	27.15	28.34	22.18	18.97	26.05
EBIT Margin %	25.79	27.31	21.3	18.16	25.36
Income From Continuing Operations Margin %	25.94	23.09	22.63	22.24	26
Net Income Margin %	25.94	23.09	22.63	22.24	26
Net Avail. For Common Margin %	25.94	23.09	22.63	22.24	26
Normalized Net Income Margin	16.94	17.54	14.68	14.89	20.52
Levered Free Cash Flow Margin	28.86	34.12	32.79	31.81	34.33
Unlevered Free Cash Flow Margin	28.86	34.12	32.79	31.81	34.33
Asset Turnover
Asset Turnover	0.55	0.54	0.5	0.44	0.41
Fixed Assets Turnover	13.66	17.24	20.59	22.59	24.53
Receivables Turnover (Average Receivables)	2.83	2.83	2.91	2.82	2.82
Short Term Liquidity
Current Ratio	3.23	3.7	3.94	4.24	4.51
Quick Ratio	3.18	3.65	3.86	4.17	4.44
Operating Cash Flow to Current Liabilities	0.77	0.91	0.78	0.77	0.78
Days Sales Outstanding (Average Receivables)	129.17	128.78	125.3	129.23	129.63
Average Days Payable Outstanding	19.1	15.8	18.57	19.72	16.21
Long Term Solvency
Total Debt/Equity	2.78	1.87	1.64	1.2	1.3
Total Debt / Total Capital	2.71	1.84	1.61	1.19	1.28
LT Debt/Equity	2.27	1.5	1.34	1	1.13
Long-Term Debt / Total Capital	2.21	1.47	1.31	0.99	1.11
Total Liabilities / Total Assets	25.6	23.71	22.65	21.42	20.54
Total Debt / EBITDA	0.15	0.1	0.12	0.12	0.1
Net Debt / EBITDA	-3.81	-4.24	-6.03	-8.31	-6.77
Total Debt / (EBITDA - Capex)	0.15	0.1	0.12	0.12	0.1
Net Debt / (EBITDA - Capex)	-3.89	-4.36	-6.2	-8.79	-6.96
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.7	26.33	16.44	9.68	16.2
Gross Profit, 1 Yr. Growth %	31.9	27.55	14.74	9.1	21.38
EBITDA, 1 Yr. Growth %	33.05	30.86	-8.39	-5.38	59.28
EBITA, 1 Yr. Growth %	34.29	31.85	-8.85	-6.22	59.58
EBIT, 1 Yr. Growth %	31.99	33.8	-9.18	-6.48	62.21
Earnings From Cont. Operations, 1 Yr. Growth %	26.2	12.47	14.11	7.79	35.84
Net Income, 1 Yr. Growth %	26.2	12.47	14.11	7.79	35.84
Normalized Net Income, 1 Yr. Growth %	27.8	30.83	-2.58	11.28	60.11
Diluted EPS Before Extra, 1 Yr. Growth %	24.21	11.44	14.07	7.33	34.16
Accounts Receivable, 1 Yr. Growth %	44.75	13.54	13.08	13.16	18.97
Net Property, Plant and Equip., 1 Yr. Growth %	6.43	-5.82	0.98	-0.97	15.02
Total Assets, 1 Yr. Growth %	34.08	25.29	25.88	23.03	24.17
Tangible Book Value, 1 Yr. Growth %	57.05	38.13	34.77	29.68	29.12
Common Equity, 1 Yr. Growth %	36.07	28.47	27.63	24.99	25.57
Cash From Operations, 1 Yr. Growth %	26.04	38.68	2.09	16.77	19.61
Capital Expenditures, 1 Yr. Growth %	100.95	63.7	-4.94	93.87	-21.67
Levered Free Cash Flow, 1 Yr. Growth %	14.32	49.37	11.89	6.41	25.38
Unlevered Free Cash Flow, 1 Yr. Growth %	14.32	49.37	11.89	6.41	25.38
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	30.35	29.47	21.28	13.01	12.89
Gross Profit, 2 Yr. CAGR %	30.84	29.71	20.97	11.89	15.08
EBITDA, 2 Yr. CAGR %	31.1	31.95	9.49	-6.9	22.77
EBITA, 2 Yr. CAGR %	31.55	33.07	9.63	-7.55	22.33
EBIT, 2 Yr. CAGR %	30.2	32.9	10.24	-7.84	23.17
Earnings From Cont. Operations, 2 Yr. CAGR %	28.58	19.14	13.29	10.91	21.01
Net Income, 2 Yr. CAGR %	28.58	19.14	13.29	10.91	21.01
Normalized Net Income, 2 Yr. CAGR %	29.67	29.31	12.9	4.12	33.48
Diluted EPS Before Extra, 2 Yr. CAGR %	26.71	17.65	12.75	10.65	20
Accounts Receivable, 2 Yr. CAGR %	37.91	28.2	13.31	13.12	16.03
Net Property, Plant and Equip., 2 Yr. CAGR %	41.83	0.12	-2.48	-0	6.73
Total Assets, 2 Yr. CAGR %	35.72	29.61	25.59	24.45	23.6
Tangible Book Value, 2 Yr. CAGR %	23.91	47.28	36.44	32.2	29.4
Common Equity, 2 Yr. CAGR %	35.31	32.22	28.05	26.3	25.28
Cash From Operations, 2 Yr. CAGR %	33.17	32.21	18.99	9.18	18.18
Capital Expenditures, 2 Yr. CAGR %	-5.96	81.37	24.75	35.76	23.23
Levered Free Cash Flow, 2 Yr. CAGR %	32.62	30.67	29.28	9.12	15.51
Unlevered Free Cash Flow, 2 Yr. CAGR %	32.62	30.67	29.28	9.12	15.51
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	28.49	29	24.97	17.29	14.06
Gross Profit, 3 Yr. CAGR %	30.14	29.73	24.51	16.88	14.97
EBITDA, 3 Yr. CAGR %	33.23	31.02	16.84	4.29	11.35
EBITA, 3 Yr. CAGR %	33.89	31.65	17.3	4.07	10.9
EBIT, 3 Yr. CAGR %	33.74	31.39	17.06	4.36	11.27
Earnings From Cont. Operations, 3 Yr. CAGR %	35.97	22.97	17.44	11.43	18.66
Net Income, 3 Yr. CAGR %	35.97	22.97	17.44	11.43	18.66
Normalized Net Income, 3 Yr. CAGR %	33.34	30.06	17.66	12.36	20.18
Diluted EPS Before Extra, 3 Yr. CAGR %	34.04	21.4	16.45	10.91	17.99
Accounts Receivable, 3 Yr. CAGR %	36.97	29.25	22.95	13.26	15.04
Net Property, Plant and Equip., 3 Yr. CAGR %	28.36	23.74	0.41	-1.98	4.77
Total Assets, 3 Yr. CAGR %	35.28	32.15	28.36	24.73	24.36
Tangible Book Value, 3 Yr. CAGR %	30.11	28.48	42.99	34.15	31.17
Common Equity, 3 Yr. CAGR %	35.74	32.99	30.67	27.02	26.06
Cash From Operations, 3 Yr. CAGR %	33.17	34.98	21.29	18.24	12.55
Capital Expenditures, 3 Yr. CAGR %	-3.4	13.12	46.23	44.5	13.02
Levered Free Cash Flow, 3 Yr. CAGR %	34.38	37.98	24.08	21.16	14.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	34.38	37.98	24.08	21.16	14.29
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	29.06	27.44	25.56	22.35	19.99
Gross Profit, 5 Yr. CAGR %	31.66	29.02	26.4	22.28	20.65
EBITDA, 5 Yr. CAGR %	35.47	31.7	23.17	14.29	19.18
EBITA, 5 Yr. CAGR %	36.13	32.41	23.6	14.29	19.29
EBIT, 5 Yr. CAGR %	36.14	33.17	23.79	14.01	19.46
Earnings From Cont. Operations, 5 Yr. CAGR %	47.48	40.68	26.4	18	18.85
Net Income, 5 Yr. CAGR %	47.48	40.68	26.4	18	18.85
Normalized Net Income, 5 Yr. CAGR %	36.56	33.15	24.75	18.99	23.75
Diluted EPS Before Extra, 5 Yr. CAGR %	44.09	37.76	25.08	16.98	17.85
Accounts Receivable, 5 Yr. CAGR %	33.4	30.59	26.96	22.54	20.13
Net Property, Plant and Equip., 5 Yr. CAGR %	18.42	15.85	15	13.63	2.89
Total Assets, 5 Yr. CAGR %	33.97	32.99	31.32	29.01	26.43
Tangible Book Value, 5 Yr. CAGR %	36.51	35.57	32.61	29.96	37.39
Common Equity, 5 Yr. CAGR %	35.01	34.86	32.61	30.28	28.49
Cash From Operations, 5 Yr. CAGR %	47.06	39.63	27.3	24	20.04
Capital Expenditures, 5 Yr. CAGR %	-16.31	15.47	7	21.68	36.56
Levered Free Cash Flow, 5 Yr. CAGR %	47.28	31.76	32.32	25.62	20.58
Unlevered Free Cash Flow, 5 Yr. CAGR %	47.28	31.76	32.32	25.62	20.58